Hi Mike,
There are a variety of approaches to controlling tinea versicolor, largely involving prevention and topical preparations. Since oral triazole antifungal agents like Diflucan (fluconazole) tend have more side effects (e.g., headache, dizziness, diarrhea, stomach pain, heartburn, change in ability to taste food), they often aren't tried until topical treatments have proven not suitably effective.
I think it is not appropriate to directly ask one's physician for a prescription of any sort. However, after having done some homework it is appropriate to ask the doctor what he or she thinks about a particular drug's potential to resolve the medical condition at issue.
In this regard, there is some evidence suggesting fluconazole's effectiveness and safety in treating tinea versicolor (*see below).
Drugs used to treat tinea versicolor would not be expected to have any healing effect on sea bather's eruption ("sea lice" bites) and vice-versa. SBE is best prevented and treated as outlined in the following article:
Dealing With Sea Bather's Eruption (SBE)
http://www.awoosh.com/Doc Vikingo's Resource Page/SBE.htm
This is educational only and does not constitute or imply a doctor-patient relationship. It is not medical advice to you or any other individual and should not be construed as such.
Regards.
DocVikingo
*"J Dermatol. 2005 Jan;32(1):19-21.
Oral fluconazole in the treatment of tinea versicolor.
Karakas M, Durdu M, Memisoglu HR.
Cukurova University, School of Medicine, Department of Dermatology, Adana, Turkey.
This study was designed to assess the efficacy, tolerability, and safety of oral fluconazole given at 300 mg once weekly for two weeks in the treatment of tinea versicolor. Enrolled into the study were 44 subjects with tinea versicolor, provisionally confirmed by the detection of fungal hyphae in KOH wet mounts and Wood's lamp examination. Four subjects were classified as dropouts because no information was obtained from them after the baseline visit. Subjects were treated for two weeks orally with fluconazole 300 mg weekly and followed at the 1st, 2nd, 4th and 12th weeks of treatment. The study included 40 subjects (26 males and 14 females, mean age 29 years, range 19-48 years). At the week 4 visit, 30 (75%) patients showed a complete cure and 31 (77.5%) patients showed mycologic cure. Ten (25%) patients had no significant response to therapy. At the final follow-up visit (week 12), none of the patients showing complete or mycologic cures exhibited a recurrence. No adverse effects were observed in any of the patients treated. We believe that, due to the low incidence of side effects, shorter treatment duration, and increased adaptation of the patients, fluconazole can be used in the treatment of tinea versicolor with confidence."